Merck, Actover’s reliable partner in the transfer of the most advanced pharmaceutical technologies to Iran

Author:
Actoverco
Date:
23 January 2024
همکاری اکتوور با مرک

Actover Pharmaceutical Company has been successfully present in the Iranian pharmaceutical market for over half a century. They have achieved this with the help of the highest standards and the most advanced technologies and equipment in the world. As a result, they have gained the attention of major foreign companies, including Merck.

Merck, Actover’s reliable partner in the transfer of the most advanced pharmaceutical technologies to Iran

Merck, a German company, is one of the oldest manufacturers of drugs, chemicals, and health materials globally, and it is a leading name in the research and development (R&D) field in these sectors. The company exports its products to over 60 countries worldwide and is renowned for its innovative technology in the pharmaceutical industry.

Merck’s production groups manufacture over 20,000 specialized pharmaceuticals, laboratory products, and special chemicals across various sectors.

This company has started its activity in the field of trading and selling drugs in Iran since 1968.

Actover Pharmaceutical Company has been successfully present in the Iranian pharmaceutical market for over half a century. They have achieved this with the help of the highest standards and the most advanced technologies and equipment in the world. As a result, they have gained the attention of major foreign companies, including Merck.

Aktovar is a company committed to producing high-quality pharmaceutical products using the latest technology, expert personnel, and smart selection of new products. It is proud to have obtained the highest quality standards and approvals, making it a capable partner of Merck in Iran and the surrounding region. It’s partnership allows it to produce drugs for this large German company and provide easy and affordable access to the latest pharmaceutical innovations from Merck.

Related Posts

M_HA2443

Scientific Conference on the Effects of Hormone Replacement Therapy (HRT) in Menopause

M_HA1634

Presentation of Actover’s latest products at the Gastrointestinal and Liver Diseases Congress

4R4A2655-Pano

Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress

4R4A0991

Actoverco’s Contribution to the 40th Annual Congress of the Iranian Psychiatric Association

WhatsApp Image 2024-09-23 at 10.46.39 AM

Introduction of Two Progesterone Drugs by Ati Pharmed at the Royan International Congress